<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>NleH effectors interact Bax inhibitor-1 block <br /> apoptosis enteropathogenic Escherichia <br /> coli infection <br /> Cordula Hemrajani, Cedric N. Berger, Keith S. Robinson, Olivier March&#195;&#168;s1, Aurelie Mousnier, Gad Frankel2 <br /> Centre Molecular Microbiology Infection, Division Cell Molecular Biology, Imperial College London, London SW7 2AZ, United Kingdom <br />  <br /> Communicated Rino Rappuoli, Novartis Vaccines, Siena, Italy, October 9, 2009 (received review May 3, 2009) <br />  <br /> The human pathogens enteropathogenic (EPEC) enterohemor-                  membrane blebbing, nuclear condensation fragmentation, <br /> rhagic Escherichia coli related mouse pathogen Citrobacter            key features late-stage apoptosis (14&#226;&#8364;&#8220;16). In <br /> rodentium subvert variety host cell signaling pathways               fact, proportion apoptotic cells monolayers infected with <br /> their plethora type III secreted effectors, including triggering        EPEC shown signi&#239;&#172;?cantly lower cells <br /> an early apoptotic response. EPEC-infected cells develop late          infected Salmonella (14). <br /> apoptotic symptoms, however. In study demonstrate                   Apoptosis occur major pathways, intrinsic <br /> the NleH family effectors, homologs Shigella effector kinase           (mitochondria- ER-mediated pathways) extrinsic <br /> OspG, blocks apoptosis. During EPEC infection, NleH effectors                 (receptor-mediated pathway) (17). Induction apoptosis the <br /> inhibit elevation cytosolic Ca2+ concentrations, nuclear conden-           intrinsic pathway involves activation Bcl-2 homology 3&#226;&#8364;&#8220;only <br /> sation, caspase-3 activation, membrane blebbing promote               proteins oligomerization proapoptotic proteins Bak and <br /> cell <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-5' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-6' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span>survival</span>. NleH1 suf&#239;&#172;?cient prevent procaspase-3               Bax (18), leading permeabilization mitochondrial outer <br /> cleavage induced proapoptotic compounds staurosporine,                 membrane release cytochrome c (17). Cytosolic cyto- <br /> brefeldin A, tunicamycin. Using C. rodentium,               chrome c interacts apoptosis activating factor 1 pro- <br /> NleH inhibits procaspase-3 cleavage bacterial attachment               caspase-9 presence dATP, forming apoptosome that <br /> sites vivo. A yeast two-hybrid screen identi&#239;&#172;?ed endoplasmic            cleaves activates executioner caspases procaspase-3, -6, <br /> reticulum six-transmembrane protein Bax inhibitor-1 (BI-1)              -7 (19, 20), turn cleave numerous protein substrates, <br /> NleH-interacting partner. We mapped NleH-binding site                  leading apoptosis (21). Because apoptosis relies &#239;&#172;?ne bal- <br /> the N-terminal 40 amino acids BI-1. Knockdown BI-1 resulted             ance proapoptotic antiapoptotic factors, hypothe- <br /> in loss NleH&#226;&#8364;&#8482;s antiapoptotic activity. These results indicate          sized A/E pathogens encode effector(s) antiapoptotic <br /> that NleH effectors inhibitors apoptosis act          activity neutralize EspF effects promote <span id='am-81' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-82' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-83' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-85' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span>cell survival</span>. <br /> BI-1 carry cytoprotective function.                              In study, demonstrated NleH plays role modu- <br />                                                                               lating apoptotic responses EPEC C. rodentium infec- <br />                       | <br /> Citrobacter rodentium type 3 secretion   | enterohemorrhagic           tions inhibiting caspase activation. <br />       |       | <br /> E. coli OspG Shigella <br />                                                                               Results <br />  <br /> E   nteropathogenic Escherichia coli (EPEC), enterohemorrhagic                Cells Infected EPEC &#206;&#8221;nleH Undergo Apoptosis. <span id='am-2' about='protege:TO' typeof='owl:Thing'>To</span> investigate <br />  <br />  <br />  <br />  <br />                                                                                                                                                                              MICROBIOLOGY <br />     E. coli (EHEC), mouse pathogen Citrobacter roden-                 role NleH effectors, generated double-nleH EPEC <br /> tium (reviewed refs. 1 2) closely related diarrheagenic            mutant, used infect HeLa cells. Quanti&#239;&#172;?cation the <br /> pathogens intimately adhere gut enterocytes instigate             number adherent living cells 5 h infection showed that <br /> localized effacement brush border microvilli (3), collectively             &lt;50% cells infected EPEC &#206;&#8221;nleH1&#206;&#8221;nleH2 mutant <br /> known attaching effacing (A/E) lesions. Injection bac-              remained attached, signi&#239;&#172;?cant cell loss observed <br /> terial effector proteins type III secretion integral       wild-type (WT) EPEC-infected cells compared unin- <br /> part EPEC, EHEC, C. rodentium infection strategy (4,               fected cells. Complementation EPEC mutant either <br /> 5). These pathogens encode plethora effector proteins (6, 7)             nleH1 nleH2 signi&#239;&#172;?cantly restored cell survival (Fig. 1A). <br /> that target intricate array host cell signaling processes               We explored cells infected WT, <br /> facilitate colonization, multiplication, dissemination, infec-            &#206;&#8221;nleH1&#206;&#8221;nleH2, nleH1 nleH2 complemented &#206;&#8221;nleH1&#206;&#8221;nleH2 <br /> tion (5). Importantly, 21 effectors (known core effectors)             strains exhibited apoptotic phenotypes assessing nuclear con- <br /> conserved EPEC, EHEC, C. rodentium (6),                     densation (through Hoechst staining) membrane blebbing <br /> other effectors strain-speci&#239;&#172;?c.                                           (through phase-contrast scanning electron microscopy [SEM]). <br />    NleH core effectors (8). EPEC EHEC                     We used staurosporine (STS), potent inducer apoptosis (22), as <br /> contain nleH genes (nleh1 nleH2), C. rodentium                    control. Quanti&#239;&#172;?cation number cells condensed <br /> harbors single copy nleH. NleH effectors homologous               nuclei revealed cells infected EPEC&#206;&#8221;nleH1&#206;&#8221;nleH2 <br /> the Shigella effector OspG, protein kinase prevents ubi-               mutant (15%) STS-treated cells (38%) contained signi&#239;&#172;?cantly <br /> quitination subsequent degradation phospho-I&#206;&#186;B&#206;&#177; and <br /> downstream activation transcriptional factor NF-&#206;&#186;B (9). <br /> Using C. rodentium, shown NleH increases NF-&#206;&#186;B                   Author contributions: C.H., C.N.B., O.M., A.M. designed research; C.H., C.N.B., K.S.R., <br /> activity TNF-&#206;&#177; expression mouse colonic mucosa                 A.M. performed research; C.H., C.N.B., K.S.R., A.M. analyzed data; C.H., C.N.B., <br /> confers competitive advantage mixed infections (10).                     A.M., G.F. wrote paper. <br />    Among core effectors, EspF disrupts mito-                    The authors declare con&#239;&#172;&#8218;ict interest. <br /> chondria membrane potential (11), opens tight junctions                   Freely available online PNAS open access option. <br /> (12), induces degradation antiapoptotic protein                    1 <br />                                                                               Present address: Blizard Institute Cell Molecular Science, Barts London <br /> AbcF2 (13). But despite potent proapoptotic effect EspF,               School Medicine Dentistry, London E1 2AT, United Kingdom. <br /> EPEC-infected cells exhibit early features apoptosis, including            2 <br />                                                                               To correspondence addressed. E-mail: g.frankel@imperial.ac.uk. <br /> expression phosphatidylserine cell surface cleavage             This article contains supporting information online www.pnas.org/cgi/content/full/ <br /> of cellular DNA (14, 15), undergo cell shrinkage,                  0911609106/DCSupplemental. <br />  <br />  <br />  <br /> www.pnas.org/cgi/doi/10.1073/pnas.0911609106                                                     PNAS | February 16, 2010 | vol. 107 | no. 7 | 3129&#226;&#8364;&#8220;3134 <br />  Fig. 1. Cells infected EPEC &#206;&#8221;nleH undergo apoptosis. Quanti&#239;&#172;?cation live adherent HeLa cells (A), nuclear condensation (B), membrane blebbing (C), <br /> and cytoplasmic Ca2+ (D) following infection HeLa cells WT EPEC, &#206;&#8221;nleH1&#206;&#8221;nleH2 mutant, p(nleH1) p(nleH2) complemented strains. The number <br /> of adherent cells signi&#239;&#172;?cantly reduced cells infected EPEC &#206;&#8221;nleH1&#206;&#8221;nleH2 (*) compared uninfected cells cells infected WT EPEC. <br /> Complementing mutant p(nleH1) p(nleH2) partially restored WT <span id='am-159' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-160' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-161' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-224' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> (A). The number cells displaying nuclear condensation or <br /> fragmentation (B) membrane blebbing (C) signi&#239;&#172;?cantly higher HeLa cells infected &#206;&#8221;nleH1&#206;&#8221;nleH2 treatment STS control (*) <br /> compared cells infected EPEC WT complemented mutant strains. Although signi&#239;&#172;?cant Ca2+ release observed WT EPEC-infected cells <br /> compared uninfected cells (#), HeLa cells infected &#206;&#8221;nleH1&#206;&#8221;nleH2 signi&#239;&#172;?cantly elevated cytosolic Ca2+ levels compared cells infected <br /> with WT EPEC (*) uninfected cells (**) (D). In A, B, C, nonparametric Mann-Whitney test used determine signi&#239;&#172;?cance, data did <br /> not follow Gaussian distribution. *P &lt; 0.05. In D, signi&#239;&#172;?cance tested using one-way ANOVA Bonferroni multiple-comparisons test. *,#,**P &lt; 0.05. <br />  <br />  <br />  <br /> more condensed nuclei compared uninfected cells cells                 induced apoptosis, analyzed level procaspase-3 (inac- <br /> infected WT EPEC nleH1- nleH2-complemented                      tive) Western blot analysis. Infection cells WT EPEC <br /> mutants (all &#226;&#8240;&#164;2%) (Fig. 1B Fig. S1A). Similar results                 inhibited caspase-3 cleavage induced STS (Fig. 2B, lane 2) <br /> observed membrane blebbing (Fig. 1C Fig. S1B).                         compared uninfected cells cells infected the <br />    Free cytoplasmic Ca2+ important second messenger                   &#206;&#8221;nleH1&#206;&#8221;nleH2 mutant (Fig. 2B, lanes 1 3). These data show <br /> apoptosis (reviewed ref. 23). Thus, measured cytosolic Ca2+              NleH inhibits STS-induced procaspase-3 cleavage. <br /> levels 3.5 h infection different EPEC strains using             To investigate NleH1 prevent <br /> the Ca2+-sensitive &#239;&#172;&#8218;uorescent indicator Fluo-4 Direct (Invi-                   apoptosis, transfected cells nleH1 treated with <br /> trogen) 96-well &#239;&#172;&#8218;uorometer. Although elevation cyto-                STS inducers ER stress-related apoptosis, brefeldin A <br /> solic Ca2+ concentration observed infection WT                 (BFA), tunicamycin (TUN) (24). The number transfected <br /> EPEC compared uninfected cells, signi&#239;&#172;?cantly higher cyto-                 cells cleaved caspase-3 quanti&#239;&#172;?ed immuno&#239;&#172;&#8218;uorescence. <br /> solic Ca2+ levels observed infection                      Mock-transfected cells cells transfected gfp control <br /> &#206;&#8221;nleH1&#206;&#8221;nleH2 mutant (Fig. 1D). Taken together, results                   displayed high levels cleaved caspase-3 (40&#226;&#8364;&#8220;50%), no <br /> suggest NleH effectors antiapoptotic activity.                       cleaved caspase-3 observed cells transfected nleH1 or <br />                                                                                untreated cells (Fig. 2C). These results indicate NleH1 can <br /> NleH Inhibits Cleavage Procaspase-3 Independently Its Kinase             prevent caspase-3 activation cells treated proapoptotic <br /> Activity. We used global caspase inhibitor Z-VAD-fmk                    compounds. <br /> explore observed cell loss absence nleH1                    NleH1 contains highly conserved kinase subdomains I, II, <br /> and nleH2 caspase-dependent apoptosis. The addi-                    III (9) conserved Lys (K159) subdomain II <br /> tion Z-VAD-fmk restored survival cells infected                 associated ATP-binding site. Before investigating <br /> &#206;&#8221;nleH1&#206;&#8221;nleH2 mutant, control cells treated STS                 putative kinase activity plays role antiapoptotic <br /> (Fig. 2A). These results suggest NleH1 NleH2 inhibit                  function, determined NleH protein kinase. <br /> caspase-dependent apoptosis EPEC infection.                             Toward end, puri&#239;&#172;?ed His-NleH1WT His-NleH1K159A <br />    Active (cleaved) caspase-3 main apoptosis exe-                incubated &#206;&#179;-33P-ATP presence absence the <br /> cutioner. To investigate NleH effectors prevent                    general kinase substrate myelin basic protein (MBP); Abl kinase <br /> apoptosis, infected HeLa cells WT EPEC,                            used positive control. Autoradiography revealed auto- <br /> &#206;&#8221;nleH1&#206;&#8221;nleH2 mutant, complemented mutant strain.                        phosphorylation NleH1WT strong MBP phosphorylation by <br /> Whereas 40% HeLa cells infected double-nleH mutant                 Abl NleH1WT. NleH1K159A phosphorylated itself nor <br /> exhibited cleaved caspase-3 staining, 3% cells infected                MBP (Fig. S2A). These results indicate NleH1 auto- <br /> with WT EPEC (Fig. S1C) 20% cells infected                     phosphorylated protein kinase. We investigated the <br /> complemented strain (Table S4) demonstrated caspase-3 activa-                  kinase activity NleH1 plays role antiapoptotic activity by <br /> tion. To examine NleH protect HeLa cells STS-                 incubating NleH1K159A-transfected cells different pro- <br />  <br /> 3130 | www.pnas.org/cgi/doi/10.1073/pnas.0911609106                                                                                        Hemrajani et al. <br />                                                                                           Fig. 2. NleH inhibits caspase-3 activation. (A) Z- <br />                                                                                          VAD-fmk inhibits EPEC-induced cell detachment. <br />                                                                                          HeLa cells treated caspases inhibitor Z-VAD- <br />                                                                                          fmk infected WT EPEC, &#206;&#8221;nleH1&#206;&#8221;nleH2 <br />                                                                                          mutant, p(nleH1)- p(nleH2)-complemented <br />                                                                                          strains, number live adherent cells <br />                                                                                          counted. Z-VAD-fmk inhibited loss STS- <br />                                                                                          treated control EPEC &#206;&#8221;nleH1&#206;&#8221;nleH2-infected <br />                                                                                          cells. *P &lt;.05. The nonparametric Mann-Whitney <br />                                                                                          test used determine signi&#239;&#172;?cance, because <br />                                                                                          data did follow Gaussian distribution. <br />                                                                                          *P &lt;.05. (B) Analysis procaspase-3 cleavage. HeLa <br />                                                                                          cell lysates, infected 1 h WT EPEC or <br />                                                                                          &#206;&#8221;nleH1&#206;&#8221;nleH2 mutant treated 3 h with <br />                                                                                          STS, analyzed Western blot procas- <br />                                                                                          pase-3 (inactive) tubulin-control antibodies. <br />                                                                                          Untreated uninfected lysates served controls <br />                                                                                          (lane 4). STS treatment induced capase-3 activation <br />                                                                                          (lane 1). Infection WT EPEC inhibited STS- <br />                                                                                          induced procaspase-3 cleavage (lane 2), whereas <br />                                                                                          infection &#206;&#8221;nleH1&#206;&#8221;nleH2 mutant did (lane <br />  <br />  <br />  <br />  <br />                                                                                                                                                  MICROBIOLOGY <br />                                                                                          3). (C) Cleaved caspase-3 (active) quanti&#239;&#172;?ed in <br />                                                                                          cells transfected nleH1, nleHK159A, pEGFP <br />                                                                                          treated STS, BFA, TUN. Anti-HA (green) <br />                                                                                          anti&#226;&#8364;&#8220;cleaved caspase-3 (red) used detect <br />                                                                                          HA-NleH1 NleH1K159A active caspase-3 by <br />                                                                                          immuno&#239;&#172;&#8218;uorescence. Ectopic expression NleH1 <br />                                                                                          NleH1K159A prevented cleavage procaspase-3 <br />                                                                                          treatment STS (B), BFA (C), TUN (D) <br />                                                                                          compared mock-transfected cells cells <br />                                                                                          transfected pEGFP. The nonparametric Mann- <br />                                                                                          Whitney test used determine signi&#239;&#172;?cance. <br />                                                                                          *P &lt;.05. (D) NleH inhibits caspase-3 activation in <br />                                                                                          vivo. Colonic sections extracted mice infected <br />                                                                                          9 days WT &#206;&#8221;nleH C. rodentium were <br />                                                                                          immunostained anti&#226;&#8364;&#8220;cleaved caspase-3 anti- <br />                                                                                          body, anti-intimin antibody (to <span id='am-1' about='rdfs:label' typeof='owl:Thing'>label</span> bacteria), and <br />                                                                                          Hoechst. Speci&#239;&#172;?c caspase-3 activation bacterial <br />                                                                                          attachment sites observed mice infected with <br />                                                                                          &#206;&#8221;nleH mutant, infected WT <br />                                                                                          C. rodentium. <br />  <br />  <br />  <br /> apoptotic compounds. As shown Fig. 2C, cells transfected   level WT (Fig. S2C). Together, trans- <br /> both nleH1K159A nleH1WT equally inhibited caspase-3 acti-      fection infection data suggest NleH&#226;&#8364;&#8482;s kinase activity does <br /> vation treatment STS, BFA, TUN. However, infec-      major role cytoprotection function. <br /> tion HeLa cells double-nleH mutant complemented           To explore NleH exert antiapoptotic <br /> with nleH1K159A resulted intermediate cell detachment phe-      activity context vivo infection, infected C57BL/ <br /> notype (Fig. S2C). Quantitative analysis revealed com-        6 mice WT &#206;&#8221;nleH C. rodentium. Both strains colonized <br /> plementing double-nleH mutant plasmid encoding          colon similar levels (10). Immuno&#239;&#172;&#8218;uorescence thin <br /> NleH1K159A signi&#239;&#172;?cantly increased number adherent cells,    colonic sections revealed increased cleaved caspase-3 levels only <br />  <br /> Hemrajani et al.                                                                      PNAS | February 16, 2010 | vol. 107 | no. 7 | 3131 <br />  Fig. 3. NleH1 NleH2 target BI-1 pathway. (A) NleH&#226;&#8364;&#8220;BI-1 protein interaction. Yeast cells cotransformed pGBT9-NleH1/pGAD-BI-1 [I] pGBT9- <br /> NleH1/pGAD-BI-11&#226;&#8364;&#8220;40 [II] grew selective medium, yeast cotransformed pGBT9/pGAD-BI-1 [III], pGBT9-NleH1/pGAD [IV], pGBT9/pGAD-BI- <br /> 11&#226;&#8364;&#8220;40 [V] did not, demonstrating speci&#239;&#172;?c interaction NleH1 BI-1 BI-11&#226;&#8364;&#8220;40. (B) NleH1 BI-1 colocalized. HeLa cells cotransfected HA-NleH1 <br /> and Myc-BI-1 immunostained anti-HA (red) anti-Myc (green) antibodies. NleH1 colocalized BI-1 reticular perinuclear region (white arrows) <br /> and localized plasma membrane (red arrows). (C) BI-1 knockdown veri&#239;&#172;?ed semiquantitative RT-PCR. GADPH RT-PCR used total <br /> mRNA concentration control. (D) Quanti&#239;&#172;?cation cytoplasmic Ca2+ level HeLa cells depleted BI-1 treated control siRNA. Whereas signi&#239;&#172;?cant <br /> Ca2+ release observed uninfected cells transfected BI-1 control siRNA, signi&#239;&#172;?cant increase Ca2+ release observed BI-1&#226;&#8364;&#8220;depleted cells <br /> infected WT EPEC compared infected cells transfected control siRNA. Signi&#239;&#172;?cance tested using one-way ANOVA Bonferroni multiple- <br /> comparisons test. *P &lt; 0.05. (E) Quanti&#239;&#172;?cation infection live adherent HeLa cells depleted BI-1 treated control siRNA. The number of <br /> adherent cells treated BI-1 siRNA infected WT EPEC similar &#206;&#8221;nleH1&#206;&#8221;nleH2-infected cells signi&#239;&#172;?cantly lower cells <br /> treated control siRNA infected WT EPEC. Signi&#239;&#172;?cance tested using one-way ANOVA Bonferroni multiple-comparisons test. *P &lt; 0.05. <br />  <br />  <br />  <br /> in mice infected &#206;&#8221;nleH mutant strain (Fig. 2D).                          BI-1 Colocalizes NleH Is Essential Cytoprotection During <br /> These results demonstrate NleH inhibit apoptosis                    EPEC Infection. To investigate colocalization NleH BI-1, we <br /> in vivo.                                                                          cotransfected HeLa cells vectors encoding myc-tagged BI-1 <br />                                                                                   HA-tagged NleH1. As shown Fig. 3B, NleH1 BI-1 <br /> NleH Effectors Interact BI-1. To identify signaling pathways             colocalized reticular perinuclear structures, NleH <br /> by NleH effectors able inhibit apoptosis,                     plasma membrane well. <br /> performed yeast two-hybrid (Y2H) screen using NleH1 bait                        To explore BI-1 directly involved anti- <br /> and commercial HeLa cDNA library prey. A binding partner                     apoptotic phenotype, treated HeLa cells BI-1 control <br /> identi&#239;&#172;?ed screen Bax inhibitor-1 (BI-1), evolutio-                  (scrambled) siRNA. Knockdown BI-1 expression con- <br /> narily conserved apoptosis inhibitor (25, 26). The interaction of <br />                                                                                   &#239;&#172;?rmed semiquantitative RT-PCR using GADPH total <br /> BI-1 NleH1 NleH2 con&#239;&#172;?rmed direct Y2H <br /> assay (Fig. 3A Fig. S3C).                                                     mRNA control (Fig. 3C). The cells infected WT <br />    Sequence alignment NleH Shigella homolog OspG                       EPEC, cytosolic Ca2+ levels measured 3.5 h later. As <br /> revealed NleH effectors contain N-terminal 100 amino                      shown Fig. 3D, level cytosolic Ca2+ 20% higher in <br /> acids fragment missing OspG (Fig. S3A). To inves-                    infected BI-1 knockdown cells compared infected cells <br /> tigate region involved BI-1 binding, deleted                treated control siRNA. No signi&#239;&#172;?cant difference was <br /> the &#239;&#172;?rst 300 bp nleH1 tested truncated NleH1                   observed uninfected cells treated BI-1 those <br /> still binds BI-1 using Y2H assay. The cotransformants grew                   treated control siRNA. These results suggest BI-1 <br /> selective medium (Fig. S3C), indicating N terminus                    modulates cytosolic Ca2+ levels EPEC infection. <br /> NleH1 involved binding BI-1. But despite fact                     Quanti&#239;&#172;?cation live adherent cells revealed infection of <br /> binding NleH BI-1 mediated region homologous                     BI-1&#226;&#8364;&#8220;depleted cells WT EPEC 5 h resulted signi&#239;&#172;?cant <br /> OspG, OspG interacted BI-1 Y2H screen                         cell loss (50%) compared control (scrambled) siRNA-treated <br /> (Fig. S3C) protected cells STS-induced caspase-3                         cells, demonstrating BI-1 plays important role cell sur- <br /> activation (Fig. S3B). Taken together, results demonstrate <br />                                                                                   vival EPEC infection. In addition, signi&#239;&#172;?cant difference <br /> that NleH OspG distinct intracellular functions. <br />    BI-1 six-transmembrane ER protein containing pre-                       levels remaining adherent cells observed between <br /> dicted cytoplasmic N-terminal 40&#226;&#8364;&#8220;amino acid domain (BI-11&#226;&#8364;&#8220;40).                    control BI-1 siRNA-treated cells infected EPEC <br /> To determine NleH1 binds domain, performed                      &#206;&#8221;nleH1&#206;&#8221;nleH2 mutant BI-1&#226;&#8364;&#8220;depleted cells infected WT <br /> Y2H assay. Yeast cotransformed BI-11&#226;&#8364;&#8220;40 NleH1 grew                       EPEC (Fig. 3E). The absence additive effect the <br /> on selective medium (Fig. 3A), indicating N-terminal                     deletion nleH depletion BI-1 suggests BI-1 directly <br /> domain BI-1 includes NleH-binding site.                                    involved antiapoptotic NleH-signaling pathway. <br />  <br /> 3132 | www.pnas.org/cgi/doi/10.1073/pnas.0911609106                                                                                             Hemrajani et al. <br />  Discussion                                                                                         cytosol, consist NleH-binding site, &#239;&#172;?rst 100 <br /> Whereas induction cell death defense strategy used                                  amino acids NleH, missing OspG, not <br /> host remove infected cells, bacterial pathogens use diverse                                     required NleH&#226;&#8364;&#8220;BI-1 interaction; OspG does bind BI-1. <br /> strategies inhibit apoptotic pathways. For example, Chlamydia                                      BI-1 originally identi&#239;&#172;?ed cDNA library screen for <br /> trachomatis secrets CPAF protease, inhibits apoptosis                                    human proteins inhibit cell death yeast expressing Bax, a <br /> by cleaving proapoptotic BH3-only proteins (27); Neisseria                                     proapoptotic member Bcl-2 family (26, 37). Overexpression <br /> gonorrhea injects PorB (28), blocks caspase activation                                    BI-1 mammalian cells suppresses apoptosis induced by <br /> preventing mitochondrial depolarization release cyto-                                       various stimuli, including Bax, etoposide, STS, growth factor <br /> chrome c (29); Salmonella enterica translocates type III                                       deprivation, suggesting ability prevent form <br /> secretion effector SopB, inhibits apoptosis acti-                                  apoptosis (26). Indeed, overexpression BI-1 reduces Bax <br /> vating Akt (30); Legionella pneumophila inhibits apoptosis                                  activation, procaspase cleavage, mitochondrial membrane depo- <br /> translocating type IV secretion effector SdhA (31).                                     larization, ultrastructural changes induced proapoptotic <br />    Several reports demonstrated different EPEC pro-                                      ER stress agents TUN, BFA, thapsigargin (25). These <br /> teins induce early-stage apoptosis. For example, EspF                                     data correlate observation ectopic expression of <br /> reported bind antiapoptotic protein AbcF2, leading                                   NleH1 inhibits cleavage procaspase-3 presence STS, <br /> degradation facilitating cell death (13). In addition,                                 TUN, BFA. The mechanism BI-1 inhibits <br /> targeting Map EspF mitochondria (11, 32)                                  apoptosis currently known, identi&#239;&#172;?cation bacte- <br /> trigger apoptotic signals. Moreover, studies demon-                                   rial binding partner help decipher physiological function. <br /> strated puri&#239;&#172;?ed outer membrane EPEC proteins able                                         Our data indicate NleH effectors multifunctional. <br /> induce expression TNF-&#206;&#177; activate caspase-3, leading                                      They protein kinases trigger NF-&#206;&#186;B production of <br /> apoptosis (33, 34). It notable, however, despite presence                              TNF-&#206;&#177; C. rodentium infections (10), cytopro- <br /> of proapoptotic factors stress signals induced EPEC <br />                                                                                                    tective function well. Importantly uniquely, have <br /> effectors, proportion apoptotic cells monolayers infected <br />                                                                                                    shown NleH exerts antiapoptotic activity vivo, which <br /> with WT EPEC lower cells infected Salmonella <br />                                                                                                    provides plausible explanation nleH mutant is <br /> (14). The &#239;&#172;?rst indication EPEC antiapoptotic activity <br /> was provided Roxas et al. (35), reported EPEC induces                                  outcompeted WT strain mixed infections (10). <br /> phosphorylation EGFR. Interestingly, similar activity                                          The gastrointestinal epithelium high turnover rate and <br /> recently H. pylori, activates prosurvival phos-                                 renews 3&#226;&#8364;&#8220;5 days process involving proliferation, differ- <br /> phoinositide 3-kinase/Akt pathway EGFR, increasing                                     entiation, apoptosis (38). A high rate apoptosis result <br /> expression antiapoptotic factor Bcl-2 decreasing                                        detachment shedding enterocytes, asso- <br /> expression proapoptotic factor Bax (36).                                                    ciated bacteria. A recent report shown Shigella uses the <br />    In work, demonstrated EPEC counteracts                                    effector protein OspE, modulates integrin-linked kinase to <br /> proapoptotic signals translocating T3SS effectors NleH1                                     inhibit cell detachment exfoliation mucosal epithelial cells <br /> and NleH2, block caspase-3 activation, cytosolic Ca2+                                        (39). Similarly, expression NleH facilitate pathogenesis by <br /> accumulation, nuclear condensation fragmentation, mem-                                         slowing enterocyte loss sustain colonization attached, <br /> brane blebbing cell death detachment, OspG                                         extracellular, EPEC, EHEC, C. rodentium bacteria. <br /> (9) does antiapoptotic effect. Moreover, <br /> whereas inhibition NF-&#206;&#186;B activation OspG dependent                                     Materials Methods <br /> its kinase activity, demonstrated kinase activity                                 The bacterial strains (Table S1), plasmids (Table S2), primers (Table S3), growth <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                    MICROBIOLOGY <br /> of NleH1 essential antiapoptotic function,                                 conditions, molecular biology, protein puri&#239;&#172;?cation, kinase assay, Y2H assay, <br /> it appears increase cytoprotective activity.                                                experiments cultured cells mice used study described in <br />    Our results demonstrate NleH effectors inhibit apop-                                       SI Materials Methods. <br /> tosis mechanism involving BI-1. BI-1 six-trans- <br />                                                                                                    ACKNOWLEDGMENTS. We thank Siouxsie Wiles Francis Girard for <br /> membrane protein localized ER membrane,                                          assisting vivo work Claude Parsot providing ospG <br /> it exerts cytoprotective function (26, 37). We                                  transfection vector. This work supported grants Medical <br /> cytosolic N-terminal 40 amino acids BI-1, face                                        Research Council Wellcome Trust. <br />  <br />  1. Nataro JP, Kaper JB (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11:142&#226;&#8364;&#8220;          11. Nougayr&#195;&#168;de JP, Donnenberg MS (2004) Enteropathogenic Escherichia coli EspF is <br />     201.                                                                                               targeted mitochondria required initiate mitochondrial death <br />  2. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S (2005) Citrobacter rodentium                   pathway. Cell Microbiol 6:1097&#226;&#8364;&#8220;1111. <br />     mice man. Cell Microbiol 7:1697&#226;&#8364;&#8220;1706.                                                   12. McNamara BP, et al. (2001) Translocated EspF protein enteropathogenic Escherichia <br />  3. Knutton S, Lloyd DR, McNeish AS (1987) Adhesion enteropathogenic Escherichia                    coli disrupts host intestinal barrier function. J Clin Invest 107:621&#226;&#8364;&#8220;629. <br />     coli human intestinal enterocytes cultured human intestinal mucosa. Infect              13. Nougayr&#195;&#168;de JP, Foster GH, Donnenberg MS (2007) Enteropathogenic Escherichia coli <br />     Immun 55:69&#226;&#8364;&#8220;77.                                                                                    effector EspF interacts host protein Abcf2. Cell Microbiol 9:680&#226;&#8364;&#8220;693. <br />  4. Frankel G, et al. (1998) Enteropathogenic enterohaemorrhagic Escherichia coli:             14. Crane JK, Majumdar S, Pickhardt DF, 3rd (1999) Host cell death enteropathogenic <br />     More subversive <br /> </body></html>